From the Publisher:  

     Heart Failure is a devastating disease of epidemic proportions.  Physicians are faced with an increasingly large choice of treatment options and questions including:  how different genetic, racial and gender backgrounds can influence a patient's response; how to monitor treatment once it has begun; and what side-effects can be expected from these agents.

     Heart Failure:  Pharmacologic Management is the essential guide for physicians working with these issues to optimize their use of pharmacologic therapy for patients with heart failure.

     This extensively referenced text provides both the biologic and pathologic underpinning for the use of each pharmacologic agent currently recommended, including the clinical investigations that have led to our understanding of the risks and benefits associated with the use of these drugs.  In addition, this book reviews several areas, including vasopressin antagonists, that are under active investigation, but which are expected to prove fruitful in the therapy of patients with heart failure.

     Heart Failure:  Pharmacologic Management is written by individuals with extensive expertise within the field and is the only text to focus on pharmacologic therapy.  It will assist the practitioner in easily making sense of the extensive number of treatment agents available and should be considered a vital contribution to your bookshelf.
 

Table of Contents:

Chapter 1.     Diuretics in Congestive Heart Failure

Chapter 2.     Use of Digoxin in the Treatment of Heart Failure

Chapter 3.     Renin-Angiotensin System and Angiotensin Converting Enzyme Inhibitors in Chronic Heart Failure

Chapter 4.     Angiotensin Receptor Blockers in the Treatment of Heart Failure

Chapter 5.     Beta Blockers

Chapter 6.     Aldosterone Antagonism in the Pharmacological Management of Chronic Heart Failure

Chapter 7.     Inotropic Therapy in Clinical Practice

Chapter 8.     AntiArrhythmic Therapy in Heart Failure

Chapter 9.     Treating the Hypercoaguable State of Heart Failure:  Modifying the Risk of Arterial and Venous Thromboembolism

Chapter 10.   Vasodilator and Nitrates

Chapter 11.   Natriuretic Peptides for the Treatment of Heart Failure

Chapter 12.   Immune Modulatory Therapies in Heart Failure:  Using Myocarditis to Gain Mechanistic insights

Chapter 13.   The Role of Vasopressin and Vasopressin Antagonists in Heart Failure

Chapter 14.   Role of Erythropoietin in the Correction of Anemia in Patients with Heart Failure

Chapter 15.   Endothelin Antagonism in Cardiovascular Disease

Chapter16.   Pharmacogenetics

Chapter 17.   Management of Diastolic Dysfunctions

Chapter 18.   Multidrug Pharmacy for Treatment of Heart Failure:  An Algorithm for the Clinician

INDEX